Brazil: Gilead cuts tenofovir price in half.
A U.S. activist campaign, centered in the San Francisco area near Gilead's headquarters, helped get this major price reduction for Brazil's model HIV treatment program.
D000225:Adenine / Q000031:analogs & derivatives* / Q000191:economics; D001938:Brazil; D016527:Drug Costs; D063065:Organophosphonates / Q000191:economics*; D018894:Reverse Transcriptase Inhibitors / Q000191:economics*; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine